MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 93 filers reported holding MERUS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,891,639 | +222.8% | 122,631 | +260.4% | 1.34% | +226.3% |
| Q2 2023 | $895,931 | +6.0% | 34,027 | -26.0% | 0.41% | -40.5% |
| Q1 2023 | $845,609 | +14.1% | 45,957 | +24.2% | 0.69% | +62.9% |
| Q3 2022 | $741,000 | -19.1% | 36,994 | -8.6% | 0.42% | -23.5% |
| Q2 2022 | $916,000 | +14.1% | 40,481 | +33.2% | 0.55% | +8.2% |
| Q1 2022 | $803,000 | -53.1% | 30,388 | -43.6% | 0.51% | -62.5% |
| Q4 2021 | $1,712,000 | – | 53,840 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |